![Myasthenia gravis](https://www.adcreviews.com/wp-content/uploads/2022/10/Myasthenia-gravis-240x154.jpg)
Tetacept Receives FDA Orphan Drug Designation for Myasthenia Gravis (MG)
On October 12, Rongchang Bio announced that Taitacept (R&D code: RC18, trade name: Taiai®) was granted orphan drug designation by the U.S. Food and Drug
On October 12, Rongchang Bio announced that Taitacept (R&D code: RC18, trade name: Taiai®) was granted orphan drug designation by the U.S. Food and Drug